Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 905-559-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
No data are available for the intermediate but data are available for the major and minor components. Of these, 1,3-butadiene has been shown to be carcinogenic and because it is present at a concentration greater than 0.1%, mandatory classification for carcinogenicity will be required.
Key value for chemical safety assessment
Justification for classification or non-classification
No data are available for the intermediate but data are available for the major and minor components which show most are not carcinogenic.
However, the intermediate contains the minor component 1,3-butadiene at ≥0.1% and therefore is considered to be carcinogenic. A mandatory classification of: "May cause cancer" Carcinogenic Cat 1, R45 according to Dir 1999/45/EC and Cat 1A, H350 under Reg (EC) 1272/2008 is required.
Additional information
There are no specific carcinogenicity data for the intermediate. However, there are substantial data on the carcinogenicity of a number of specific components present. Of these, 1,3-butadiene has been shown to be carcinogenic.
ASTDR reviewed n-hexane in 1999 and report the material has not been tested for carcinogenicity in animals, nor has it been categorised for its potential for carcinogenicity by the International Agency for Research on cancer (IARC), the National Toxicology Program (NTP) or the EPA (ASTDR, 1999). As stated previously, n-hexane is not mutagenic, nor does it contain structural alerts associated with carcinogenicity.
There are no lifetime animal studies available on cyclohexane. However, it is a simple aliphatic chemical and neither cyclohexane nor its metabolites carry alerts for genotoxic activity. It has been shown to be non-genotoxic both in vitro and in vivo. These observations indicate that cyclohexane is not expected to be a genotoxic carcinogen. This conclusion is concordant with that in the EU RAR (2004).
In a chronic gavage investigation, male and female rats and mice were administered 4-vinylcyclohexene in corn oil for 103 weeks at doses of 200 and 400 mg/kg (NTP, 1986). In rats, poor survival reduced the sensitivity of the study for detecting the possible carcinogenic effects of 4-vinylcyclohexene and the NTP concluded the study was an inadequate assessment of carcinogenicity. Gavage (oral) administration of 4-vinylcyclohexene to mice was associated with the occurrence of neoplastic lesions in ovary, lung, haematopoietic system and adrenal gland. This study was considered an inadequate study of carcinogenicity in male mice because of extensive and early mortality at the high dose. In females, 4-vinylcyclohexene significantly increased the incidence of several types of uncommon ovarian tumours in both dose groups. The incidence of adrenal gland tumours was also increased in females; however it was unclear if this was a direct effect of 4-vinylcyclohexene or secondary altered ovarian function. Overall, NTP concluded that the occurrence of ovarian tumours provided clear evidence of potential carcinogenicity of 4-vinylcyclohexene in the mouse. No NOAELs were identified but the LOAEL in female mice was 200 mg/kg.
Based on carcinogenicity studies in rats and mice and lack of evidence of carcinogenicity in humans toluene is considered not to be carcinogenic (NTP (1990); Huff J (2003); Gibson and Hardisty (1983)). According to the EU RAR (2003), “the only useful epidemiological cancer study which has been found does not show an excess of tumours in toluene-exposed workers". Toluene has also been evaluated by IARC in 1989 and 1999 and considered to be not classifiable as to carcinogenicity to humans.
Minor components with classification for carcinogenicity
1,3-Butadiene
(Classification: EU -Toxic T, Carcinogen Cat 1 R45; GHS/CLP - Category 1A, H350): In experimental animals, there is a marked species difference in carcinogenicity (EU RAR 2002). In the mouse, 1,3-butadiene is a potent multi-organ carcinogen. Tumours develop after short durations of exposure, at low exposure concentrations and the carcinogenic response includes rare types of tumours (NTP 1993). In the rat, fewer tumour types, mostly benign, develop at exposure concentrations of 100 to1000-times higher (Owen et al 1987). In humans a positive association was demonstrated between workplace exposure to butadiene for men employed in the styrene-butadiene rubber industry and lymphohaematopoietic cancer (leukemia) (Sathiakumar et al 2005, Graff et al 2005, Delzell et al 2006, Cheng et al 2007, Sielken et al 2006, 2007 & 2008).
Complex materials and intermediates are considered to be carcinogens if they contain ≥0.1% 1,3-butadiene.
Additional References
ATSDR (1999). Toxicological Profile for n-Hexane.U.S. Department of Health and Human Services Public Health Service Agency for Toxic Substances and Disease Registry.http://www.atsdr.cdc.gov/toxprofiles/tp113. html
EU (2002). European Union Risk Assessment Report: 1,3-butadiene. http://ecb.jrc.ec.europa.eu/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/REPORT/butadienereport019.pdf
EU RAR (2003). European Union Risk Assessment Report for Toluene. EC Joint Research Centre http: //ecb. jrc. ec. europa. eu/DOCUMENTS/Existing- Chemicals/RISK_ASSESSMENT/REPORT/toluenereport032. Pdf
EU RAR (2004). European Union Risk Assessment Report: Cyclohexane. EC Joint Research Centrehttp://ecb.jrc.ec.europa.eu/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/SUMMARY/cyclohexanesum031.pdf
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.